Three growth engines, all working. One rule: at least $60M into a single bet. Here's how my first allocation, and the assumption behind it, fell apart under a simple question — and what I did with the six months of data that followed.
Samsara was growing everywhere at once: enterprise accounts over $1M ARR up 50% YoY, emerging products at 20%+ of net-new ACV for three straight quarters, and a US-heavy revenue base with real international whitespace. The problem wasn't finding a growth opportunity. It was that I had three good ones and one $100M check to write.
My instinct: fund the thing that isn't already winning. Enterprise was compounding on its own, so I routed capital away from it entirely.
One question reframed everything: strong performance can mean strong marginal returns, not saturation. Enterprise wasn't done growing because it was easy. It might have been growing because every dollar there was working harder than a dollar anywhere else.
So I stopped asking "which market is biggest" and started asking "which dollar comes back fastest, and cleanest."
Emerging products stayed the primary bet, funded to win, but enterprise got back in the game for one specific job: new-logo acquisition, to keep enlarging the base that cross-sell would later feed on.
Click "Revised" in the widget above to see the split move: $60M emerging / $20M enterprise / $20M international, plus a scorecard to watch: attach rate, expansion ARR per customer, CAC payback, gross margin, GRR/NRR, and contribution margin by geography.
The scorecard came back mixed on purpose, that's what a scorecard is for. The read: demand and retention were fine. Delivery was the bottleneck.
Same three buckets, moved by what the data actually said: keep funding emerging products but aim new spend at fixing delivery, lean further into enterprise while its pipeline is hot, and get selective internationally instead of pulling out.
Click "Final (post-test)" above: $30M to emerging-product expansion and implementation efficiency, $17M to enterprise new-logo acquisition, $5M to the international geographies that were actually converting — on top of the $48M already committed to the initial emerging-product and international bet before this six-month checkpoint.
Every allocation decision runs through the same chain. Skipping a link in it is how "biggest market" quietly replaces "best return."
Strategic attractiveness and capital attractiveness are not the same question. Fund the market that looks biggest, and you can miss the dollar that pays back fastest.